MedPath

Clinical Study to Evaluate the Blood Triglyceride Decreasing Effect and Safety of Korean Post-Fermented Tea Extracts

Not Applicable
Completed
Conditions
Triglycerides High
Registration Number
NCT04850352
Lead Sponsor
Amorepacific Corporation
Brief Summary

This study was conducted to investigate the effects of daily supplementation of Korean Post-Fermented Tea(Heukcha) Extracts on improvement of Blood Triglyceride Level.

Detailed Description

This study was a 8 week, randomized, multicenter, double-blind, placebo-controlled, parallel-design human trial.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Male and female subjects older than 19 years old
  • Who has fasting blood triglyceride levels ≥ 150 mg/dL
  • Who voluntarily agreed to participate in the study and signed an informed consent form
Exclusion Criteria
  • Those who are taking functional food designed for dyslipidemia reduction within 4 weeks before study participation
  • Those who have been diagnosed and are on medication with dyslipidemia, cardiovascular disease, kidney disease, liver disease or thyroid disease within 4 weeks before study participation
  • Fasting plasma glucose >126 mg/dL or treatment with medications including oral hypoglycemic agents or insulin
  • Who has used or is expected to inevitably use prohibited concomitant medications during the study
  • Women who is pregnant /breast-feeding, or who has childbearing potential and does not use available contraceptives
  • Who has dosed other study medications within 30 days before screening
  • Who is determined ineligible for study participation by investigators for any other reasons

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in fasting triglyceridesBaseline, Week 4 and Week 8
Secondary Outcome Measures
NameTimeMethod
Change in total cholesterol, LDL-C, HDL-CBaseline, Week 4 and Week 8
Change in BMI (kg/m2)Baseline, Week 4 and Week 8
Change in Waist circumference (cm)Baseline, Week 4 and Week 8

Trial Locations

Locations (3)

KangBuk Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

Seoul National University

🇰🇷

Seoul, Korea, Republic of

St. Vincent's Hospital, College of Medicine, The Catholic University of Korea

🇰🇷

Suwon, Korea, Republic of

KangBuk Samsung Medical Center
🇰🇷Seoul, Korea, Republic of

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.